Molecular glue development continues to thrive, offering exciting opportunities to target previously undruggable proteins and treat a wide range of diseases. 2024 has seen a multitude of collaborations, with Takeda and Degron Therapeutics entering a deal worth $1.2 billion.

The 3rd Molecular Glue Drug Development Summit returns as the only industry-dedicated forum bringing together 90+ experts as they showcase the latest advancements and breakthroughs in molecular glue drug development through discussions and data-driven case studies on screening tools, novel mechanisms of actions of proximity-based degrading and non-degrading molecular glues and lead optimization strategies, to streamline discovery and development of safe and effective glues.

Category: Conferences | Science, Health and Medicine | Pharmaceuticals

Date and Time: 28th January 2025 at 8:00 am to 30th January 2025 at 4:45 pm

Venue details: The Royal Sonesta Boston, 40 Edwin H Land Boulevard, Boston, Massachusetts, 02142, United States